CYTOKINETICS INC

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA·FY end 12/31·CIK 1061983

CEO Pay Ratio

28:1

Robert I. Blum

CEO Total Comp

$11.9M

Robert I. Blum

Median Employee

$425,718

Revenue

$88.0M

FY 2025

Net Income

-$785.0M

FY 2025

Free Cash Flow

-$534.8M

FY 2025

Net Margin

-891.6%

Insider Net (180d)

-$26.9M

0 buys / 46 sales

CEO Pay Accountability

CEO comp as % of net income

-1.51%

For every $1,000 of profit, $-15.14 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$88.0M	$18.5M	$7.5M	$94.6M	$70.4M
Gross Profit	—	—	—	—	—	—
Operating Income	-$612.3M	-$536.2M	-$496.2M	-$324.2M	-$186.3M
Net Income	-$785.0M	-$589.5M	-$526.2M	-$389.0M	-$215.3M
Operating CF	-$510.0M	-$395.9M	-$414.3M	-$299.5M	-$142.5M
Capex	$24.8M	$3.9M	$1.4M	$11.3M	$48.9M
Free Cash Flow	-$534.8M	-$399.8M	-$415.7M	-$310.9M	-$191.4M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	-695.4%	-2902.7%	-6589.7%	-342.8%	-264.5%
Net Margin	-891.6%	-3191.1%	-6988.6%	-411.2%	-305.7%
FCF Margin	-607.5%	-2164.1%	-5521.2%	-328.6%	-271.8%
R&D / Revenue	472.5%	1837.2%	4384.1%	254.6%	227.1%
Effective Tax	—	—	—	—	—	—
Debt / Equity	-0.37	-5.27	-1.81	-6.61	0.19
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Robert I. BlumPrincipal Executive Officer · CEO	$853.1K	$5.2M	$5.1M	$772.7K	$9.7K	$11.9M
Jeffrey HessekielExecutive Vice President, Chief Legal & Administrative Officer	$85.3K	$5.8M	—	$200.0K	$954	$6.1M
Fady I. MalikExecutive Vice President, Research and Development	$629.8K	$1.8M	$1.7M	$335.1K	$20.5K	$4.5M
Andrew M. CallosExecutive Vice President, Chief Commercial Officer	$581.7K	$1.4M	$1.4M	$303.0K	$18.2K	$3.8M
Sung H. LeePrincipal Financial Officer · CFO	$572.9K	$1.4M	$1.4M	$295.6K	$17.5K	$3.8M